Go to contentGo to menuGo to searchGo to the news list

Micro et Nanomédecines Translationnelles

Main navigation

    Search

    Breadcrumb

    Soutenance de thèse de Mr Dario CARRADORI

    Soutenance de thèse de Mr Dario CARRADORI

    • Share this page on social networks
    • E-mail this page

      Send by mail


      Separated by coma
    • Print this page

    21st September 2017

    Titre : Novel nanoparticle-based drug delivery system for neural stem cell targeting and differentiation

    Directeur de Thèse : Dr Jöel EYER

    Salle Couvreur, UCL, Bruxelles, 14h

    Neural stem cells (NSCs) are located in specific regions of the central nervous system called niches. Those cells are able to self-renew and to differentiate into specialized neuronal cells (neurons, astrocytes and oligodendrocytes). Due to this differentiation property, NSCs are studied to replace neuronal cells and restore neurological functions in patients affected by neurodegenerative diseases. Several therapeutic approaches have been developed and endogenous NSC stimulation is one of the most promising. Currently, there is no active molecule or therapeutic system targeting endogenous NSCs and inducing their differentiation at the same time. The aim of the work was to provide a drug delivery system able both to target endogenous NSCs and to induce their differentiation in situ. Here, we developed and characterized lipidic nanoparticles (LNC) targeting endogenous NSCs.  A peptide called NFL-TBS.40-63, known for its affinity towards NSCs, was adsorbed at the surface of LNC. We observed that NFL-LNC specifically targeted NSC from the brain and not from the spinal cord in vitro and in vivo. To explain this specificity, we characterized and compared NFL-LNC interactions with the plasmatic membrane of both cell types. Finally, we demonstrated that by loading retinoic acid in NFL-LNC we were able to induce brain NSC differentiation in vitro and in vivo. This work contributes to the development of efficient and safe therapies for the treatment of neurodegenerative disease via the differentiation of endogenous NSCs.